Brief: Abivax Expects To Be Able To Finance Its Operating Cash Flow Requirements Into Q4 2025
09/09/2024 21:02
Sept 9 (Reuters) - Abivax SA ABVX.PA :
* ABIVAX PRESENTS FIRST-HALF 2024 FINANCIAL RESULTS
* ABIVAX SA - EXPECTS TO BE ABLE TO FINANCE ITS OPERATING
CASH
FLOW REQUIREMENTS INTO Q4 OF 2025
Source text for Eikon: ID:nGNX3lbvcD
Further company coverage: ABVX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data